CT
TAK icon

Caldwell Trust’s Takeda Pharmaceutical TAK Stock Holding History

Caldwell Trust’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-7,551
Closed -$106K – 742
2022
Q2 		$106K Hold
7,551
– – 0.01% 353
2022
Q1 		$108K Hold
7,551
– – 0.01% 357
2021
Q4 		$103K Hold
7,551
– – 0.01% 370
2021
Q3 		$124K Sell
7,551
-280
-4% -$4.7K 0.02% 336
2021
Q2 		$132K Sell
7,831
-67
-0.8% -$1.14K 0.02% 324
2021
Q1 		$144K Hold
7,898
– – 0.02% 314
2020
Q4 		$144K Hold
7,898
– – 0.02% 299
2020
Q3 		$141K Hold
7,898
– – 0.02% 290
2020
Q2 		$142K Hold
7,898
– – 0.02% 285
2020
Q1 		$120K Hold
7,898
– – 0.02% 296
2019
Q4 		$156K Buy
+7,898
New +$151K 0.02% 306

Other funds holding TAK

MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Caldwell Trust's TAK Position: Q3 2022 in Review

Caldwell Trust sold out of Takeda Pharmaceutical (TAK) in Q3 2022, closing a stake of 7,551 shares — an estimated $106K sold.

Caldwell Trust first reported a position in TAK in Q4 2019 and held it in 11 quarters. The position peaked at $156K in Q4 2019. 276 funds tracked by Wall St. Rank hold TAK as of Q3 2022.

  • Caldwell Trust reported no remaining Takeda Pharmaceutical position as of Q3 2022 after selling out during the quarter.
  • Caldwell Trust sold 7,551 Takeda Pharmaceutical shares in Q3 2022, an estimated $106K.
  • Caldwell Trust first reported a position in Takeda Pharmaceutical in Q4 2019 and held it in 11 quarters.
  • Caldwell Trust's Takeda Pharmaceutical position peaked at $156K in Q4 2019.
  • 276 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2022.

Based on Caldwell Trust's 13F filing for Q3 2022, filed 1 Oct 2025.